Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-905-6055535
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/27/2019 (Estimated)
OptionableNot Optionable
Revive Therapeutics (CVE:RVV) Frequently Asked Questions
What is Revive Therapeutics' stock symbol?
Revive Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RVV."
When is Revive Therapeutics' next earnings date?
Has Revive Therapeutics been receiving favorable news coverage?
News coverage about RVV stock has trended somewhat positive recently, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Revive Therapeutics earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Revive Therapeutics.
Who are some of Revive Therapeutics' key competitors?
Some companies that are related to Revive Therapeutics include Race Oncology (RAC), Realm Therapeutics (RLM), Hvivo (HVO), Bioxyne (BXN), biOasis Technologies (BTI), Devonian Health Group (GSD), Kane Biotech (KNE), Living Cell Technologies (LCT), Naturally Splendid Enterprises (NSP), Trillium Therapeutics (TRIL), Ibio (IBIO), Hemostemix (HEM), Anatara Lifesciences (ANR), AorTech International (AOR) and Ovoca Bio (OVB).
What other stocks do shareholders of Revive Therapeutics own?
Who are Revive Therapeutics' key executives?
Revive Therapeutics' management team includes the folowing people:
- Mr. Craig Leon, Chairman & CEO (Age 51)
- Mr. Fabio Chianelli, Pres & Director (Age 41)
- Mr. Carmelo Marrelli C.A., C.P.A., CPA, B.Comm., CA, CGA, ACIS, Chief Financial Officer (Age 48)
How do I buy shares of Revive Therapeutics?
Shares of RVV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How big of a company is Revive Therapeutics?
What is Revive Therapeutics' official website?
How can I contact Revive Therapeutics?
Revive Therapeutics' mailing address is 5 Director Crt Suite 105, WOODBRIDGE, ON L4L 4S5, Canada. The company can be reached via phone at +1-905-6055535.
MarketBeat Community Rating for Revive Therapeutics (CVE RVV)
MarketBeat's community ratings are surveys of what our community members think about Revive Therapeutics and other stocks. Vote "Outperform" if you believe RVV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RVV will underperform the S&P 500 over the long term. You may vote once every thirty days.
